Seoul, South Korea

Hong-Sun Kim

This inventor holds 2 USPTO granted patents. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2006-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong-Sun Kim. Retrieved from https://idiyas.com/inventor/hong-sun-kim-nyrbdee1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Hong-Sun Kim

Introduction

Hong-Sun Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cefdinir-related compounds. With a total of two patents to his name, Kim's work showcases his expertise and dedication to innovation.

Latest Patents

Hong-Sun Kim's latest patents include "Crystalline acid salts of cefdinir and process for preparing cefdinir using same" and "Process for the selective preparation of 3-(Z) propenyl-cephem compound." The first patent describes a method for preparing high-purity cefdinir in a high yield by treating a crystalline salt of a cefdinir intermediate with a specific acid mixture. The second patent outlines a selective preparation process for a 3-(Z)-propenyl cephem compound through a reaction involving a phosphoranylidene cephem compound and acetaldehyde.

Career Highlights

Kim is currently associated with Hanmi Pharm. Co., Ltd., where he continues to contribute to pharmaceutical innovations. His work has been instrumental in advancing the development of new medications that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Gwan-Sun Lee and Young-Kil Chang. Their collaborative efforts have further enhanced the research and development initiatives at Hanmi Pharm.

Conclusion

Hong-Sun Kim's contributions to the field of pharmaceuticals through his innovative patents reflect his commitment to advancing medical science. His work continues to impact the industry positively, paving the way for future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…